Inventor · disambiguated record
Pascal Schneider
Also filed as: SCHNEIDER PASCAL
18 granted patents·19 pending applications·323 citations·filing 1999–2021
94Inventor score
Files withBIOGEN IDEC INC6EDIMER PHARMACEUTICALS INC4BIOGEN MA INC3TOPOTARGET SWITZERLAND SA3APOTECH RES & DEV LTD2
Top patents by PatentIndex Score
37 records- 0197US7083785B2Methods of treatment by administering an anti-BCMA antibodyBIOGEN IDEC INC·Filed 2002·Granted Aug 1, 2006·151 cites·18 claims
- 0293US9650430B2Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)BIOGEN MA INC·Filed 2014·Granted May 16, 2017·8 cites·10 claims
- 0393US6869605B2BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2001·Granted Mar 22, 2005·75 cites·14 claims
- 0485US7385032B2Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteinsAPOTECH RES & DEV LTD·Filed 2002·Granted Jun 10, 2008·35 cites·12 claims
- 0584US10494416B2Methods of modulating immune responses using BCMA polypeptideBIOGEN MA INC·Filed 2017·Granted Dec 3, 2019·1 cites·7 claims
- 0682US7276241B2Methods of treating a tumor that expresses APRIL by administering BCMAAPOXIS SA·Filed 2002·Granted Oct 2, 2007·25 cites·24 claims
- 0780US7736657B2Fusion constructs containing active sections on TNF ligandsAPOXIS S A·Filed 2002·Granted Jun 15, 2010·15 cites·8 claims
- 0879US8828669B2Methods of screening for a compound that inhibits the interaction between BAFF and BCMABROWNING JEFFREY·Filed 2012·Granted Sep 9, 2014·1 cites·2 claims
- 0976US2020095305A1Methods of modulating immune responses using bcma polypeptideBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1075US8496937B2Preparation of isolated agonist anti-EDAR monoclonal antibodiesSCHNEIDER PASCAL·Filed 2010·Granted Jul 30, 2013·7 cites·35 claims
- 1168US8895003B2Pharmaceutical composition comprising EDA-1 Fusion ProteinTOPOTARGET SWITZERLAND SA·Filed 2013·Granted Nov 25, 2014·2 cites·15 claims
- 1268US8501177B2Treatment of ectodermal dysplasia with EDA1 fusion proteinsGAIDE OLIVIER·Filed 2010·Granted Aug 6, 2013·2 cites·21 claims
- 1364US2010233179A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBROWNING JEFFREY·Filed 2009·Application pending·0 cites
- 1461US8741297B2Preparation of isolated agonist anti-EDAR monoclonal antibodiesEDIMER PHARMACEUTICALS INC·Filed 2013·Granted Jun 3, 2014·1 cites·24 claims
- 1559US2009053252A1Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteinsAPOTECH RES & DEV LTD·Filed 2008·Application pending·0 cites
- 1658US2005100548A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 1756US2015218247A1Taci as an anti-tumor agentBIOGEN IDEC INC·Filed 2015·Application pending·0 cites
- 1856US2006079457A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1955US2005169924A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 2055US2004013674A1Taci as an anti-tumor agentFiled 2001·Application pending·0 cites
- 2155US2013202552A1Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteinsLTD APOTECH RES AND DEV·Filed 2013·Application pending·0 cites
- 2254US2015004129A1Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteinsTOPOTARGET SWITZERLAND SA·Filed 2014·Application pending·0 cites
- 2353US2015098944A1Fusion constructs containing active sections of tnf ligandsTOPOTARGET SWITZERLAND SA·Filed 2014·Application pending·0 cites
- 2453US2004235117A1Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteinsFiled 2004·Application pending·0 cites
- 2551US2012009211A1Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteinsTSCHOPP JUERG·Filed 2011·Application pending·0 cites
- 2651US2024101692A1Anti-april antibodies and uses thereofCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2021·Application pending·0 cites
- 2750US10426819B2Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 proteinESPOIRXLHED SARL·Filed 2018·Granted Oct 1, 2019·0 cites·17 claims
- 2847US2012189634A1Taci as an anti-tumor agentAMBROSE CHRISTINE·Filed 2011·Application pending·0 cites
- 2947US2005255547A1Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the sameTSCHOPP JURG·Filed 2002·Application pending·0 cites
- 3046US9175085B2Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonistSCHNEIDER PASCAL·Filed 2012·Granted Nov 3, 2015·0 cites·8 claims
- 3144US9925239B2Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 proteinEDIMER PHARMACEUTICALS INC·Filed 2015·Granted Mar 27, 2018·0 cites·7 claims
- 3243US9695245B2Anti-ectodysplasin antibodiesEDIMER PHARMACEUTICALS INC·Filed 2014·Granted Jul 4, 2017·0 cites·17 claims
- 3342US10526412B2Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancerUNIV GRENOBLE ALPES·Filed 2016·Granted Jan 7, 2020·0 cites·12 claims
- 3440US10300013B2Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasiasESPOIRXLHED SARL·Filed 2014·Granted May 28, 2019·0 cites·10 claims
- 3539US2004197876A1Recombinant fusion proteins and the trimers thereofFiled 2002·Application pending·0 cites
- 3634US2016272694A1Compositions and methods for the treatment of ectodermal dysplasiaEDIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3721US2002095030A1Flip genes and flip proteinsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pascal Schneider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →